Parvovirus infection in children
https://doi.org/10.22627/2072-8107-2019-18-1-22-28
Abstract
The article presents current information about the etiology, epidemiology, clinical manifestations of parvovirus infection in children. The problems of the use of laboratory tests, treatment and prevention ofinfection.
About the Authors
V. A. Anokhin
Kazan State Medical University
Russian Federation
Russian Federation
Vladimir Anokhin - MD, Professor, Head of childhood infections
A. M. Sabitova
Kazan State Medical University
Russian Federation
Russian Federation
TatianaAglyamova
T. A. Aglyamova
NaberezhnyeChelny Hospital for Infectious Diseases, Naberezhnye Chelny
Russian Federation
Russian Federation
TatianaAglyamova
E. Y. Minaeva
NaberezhnyeChelny Hospital for Infectious Diseases, Naberezhnye Chelny
Russian Federation
Russian Federation
ElenaMinaeva
N. A. Marchenkova
NaberezhnyeChelny Hospital for Infectious Diseases, Naberezhnye Chelny
Russian Federation
Russian Federation
Nina Marchenkova
O. Y. Knyazeva
NaberezhnyeChelny Hospital for Infectious Diseases, Naberezhnye Chelny
Russian Federation
Russian Federation
Oksana Knyazeva
References
1. Serjeant G.R., Topley J.M., Mason K., Serjeant B.E., Pattison J.R., Jones S.E., Mohamed R. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981: 595-597.
2. Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L.R., Cohen BJ., Mortimer P.P., Pereira M.S. Human parvovirus, the cause of erithema infectiosum (fifth disease). Lancet. 1983; 321: 1378.
3. Cossart Y.E., Field A.M., Cаnt B., Widdows D. Parvovius-like particles in human sera. Lancet. 1975; 1 (7898): 72-73.
4. Rationalization and extension of the taxonomy of the family Parvo-viridae. ICTVon-line. Code assigned: 2013.001a-aaaV: 23-24.
5. Huschen J.M., Mihneva Z., Mentis A.F., Schneider F., Aboudy Y, Grossman Z., Rudich H., Kasymbekova K., Sarv I., Nedeljkovic J., Tahita M.C., Tarnagda Z., Ouedraogo J.-B., Gerasimova A.G., Moskaleva T.N., Tikhonova N.T., Chitadze N., Forbi J.C., Faneye A.O., Otegbayo J.A., Charpentier E., Muller C.P. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J. Clin. Microbiol. 2009; 47(11): 3735-3738.
6. Schneider B., H ne A., Tolba R.H., Fischer Y.-P., Blmel J. Eis-H binger A.M. Simultaneous persistence of multiple genome variants of human parvovirus B19. J. Gen. Virol. 2008; 89: 164-176.
7. Toan N.L., Duechting A., Kremsner P.G., Song L.H., Ebinger M., Ab-erle S., Binh V.Q., Duy D.N., Torresi J., Kandolf R., Bock C.-Th. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J. Gen. Virol. 2006; 87:. 2941-2949.
8. Nguyen QT, Wong S, Heegaard ED, Brown KE. Identification and characterization of a second novel human erythrovirus variant, A6. Virology. 2002; 301:374.
9. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol. 2002; 76:9124.
10. Parsyan A, Szmaragd C, Allain JP, Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol. 2007; 88:428.
11. Lavrentieva I.N., Antipova A.Yu. Human parvovirus B19: characteristic of the pathogen, distribution and diagnosis of the infection caused by it. Infektsiya i Immunitet=Infection and Immunity. 2013; 3 (4): 311-322. (In Russ.)
12. Mortimer P.P. , Humphries R.K., Moore J.G., Purcell R.H., Young N.S. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature. 1983; 302:426.
13. Brown K.E., Anderson S.M., Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993; 262:1 14.
14. Brown K.E., Hibbs J.R., Gallinella G., Anderson S.M., Lehman E.D., McCarthy P., Young N.S. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994; 330:1192.
15. Weigel-Kelley K.A., Yoder M.C., Srivastava A. Alpha5beta1 in-tegrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta 1 integrin for viral entry. Blood. 2003; 102:3927.
16. Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J, Kodera T, Ishii T., Hirabayashi Y., Koyanagi Y., Sasaki T. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood. 2005; 106: 3449.
17. Yamashita K., Matsunaga Y., Taylor-Wiedeman J., Yamazaki S. A significant age shift of the human parvovirus B1 9 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med SciBiol. 1992; 45:49.
18. Kerr S., O'Keeffe G., Kilty C., Doyle S. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol. 1999; 57:179.
19. Anderson MJ., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., Pattison J.R., Tyrrell D.A. Experimental parvoviral infection in humans. J Infect Dis. 1985; 152:257.
20. Tikhonova N.T., Gerasimova A.G., Moskaleva T.N., Tsvirkun O.V, Chava O.O. Assessment of the spread of parvovirus infection in Moscow: Informational letter №11. Moscow: Moscow Government Health Department, 2004:1 1. (In Russ.)
21. Mossong J., Hens N., Friederichs V, Davidkin I., Broman M., Litwin-ska B., Siennicka J., Trzcinska A., Van Damme P., Beutels P., Vyse A., Shkedy Z., Aerts M., Massari M., Gabutti G. Parvovirus B19 infection in the European countries: seroepidemiology, force of infection, and maternal risk of infection. Epidemiol. Infect. 2008; 1 36(8): 1059-1068.
22. Cartter M.L., Farley T.A., Rosengren S., Quinn D.L., Gillespie S.M., Gary G.W., Hadler J.L. Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis. 1991; 163:282.
23. Gay NJ., Hesketh L.M., Cohen B.J., Rush M, Bates C., Morgan-Capner P., Miller E. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev 1994; 4:R104.
24. Gratac E., Torres P.J., Vidal J., Antoln E., Costa J., Jimnez de Anta M.T., Cararach V, Alonso P.L., Fortuny A. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis. 1995; 171: 1360-1363.
25. Harger J.H., Adler S.P., Koch W.C., Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet. Gynecol. 1998; 91: 41 3-420.
26. Kleinman S.H., Glynn S.A., Lee T.H., Tobler L., Montalvo L., Todd D., Kiss J.E., Shyamala V, Busch M.P. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007; 47(10):1756.
27. Kleinman SH, Glynn SA, Lee TH, Tobler LH, Schlumpf KS, Todd DS, Qiao H, Yu MY, Busch MP A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood. 2009; 114(17):3677.
28. FDA Biologics Guidances. www. fda. Gov / Biologics Blood Vaccines / GuidanceComplianceRegulatoryinformation/Guidances/ default.htm (Accessed on March 20, 2017).
29. Schwarz TF, Wiersbitzky S, Pambor M. Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectio-sum. J Med Virol. 1994;43(2):171.
30. Takahashi Y., Murai C., Shibata S., Munakata Y., Ishii T., Ishii K., Saitoh T., Sawai T., Sugamura K., Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A.1998; 5(14):8227.
31. Mossong J., Hens N., Friederichs V., Davidkin I., Broman M., Litwinska B., Siennicka J., Trzcinska A., Van Damme P., Beutels P., Vyse A., Shkedy Z., Aerts M., Massari M., Gabutti G. Parvovirus B19 infection in the European countries: seroepidemiology,force of infection, and maternal risk of infection. Epidemiol. Infect.-2008; 136(8):1059-1068.
32. Matveev V.A., Proschaeva N.V., Samoilovich E.O., Ermolovich M.A. Clinical and laboratory characteristics of B19 parvovirus infection. Infektsionnyye Bolezni=Infectious Diseases. 2008; 6(3): 33-37. (In Russ.)
33. Bailey J.M. Parvovirus B19 presenting with severe sepsis in a previously healthy 25-year-old female . J. Am. Board Fam. Med. 2006; 19(3): 317-319.
34. Young N.S., Brown K.E. Mechanisms of disease: Parvovirus. N. Engl. J. Med. 2004; 350(6): 586-597.
35. Waldman M., Kopp J.B. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007; 2 Suppl 1 :S47.
36. Lindblom A, Isa A, Norbeck O, Wolf S., Johansson Bo, Broliden K., Tolfvenstam T. Slow clearance of human parvovirus B19 viremia following acute infection. Clin. Infect. Dis. 2005; 41:1201. DOI: 10.1086/444503.
37. Molochkova O.V., N.Yu. Egorova, N.A. Guseva, O.V Shamsheva. To the question of differential diagnosis of infectious exanthema in children: a clinical case of infectious erythema of parvovirus etiology. Pediatrics. 2019; 98(1):159-164. (In Russ.) https://doi.org/10.24110/0031-403X-2019-98-1-159-164
38. Boeck K., Mempel M., Schmidt T., Abeck D. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis. 1998; 62:271.
39. Grilli R., Izquierdo M.J., Farina M.C. «Papular-purpuric» gloves and socks» syndrome: polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol. 1999; 41:793.
40. Oguz F, Akdeniz C, Unuvar E, Kucukbasmaci O., Sidal M. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health. 2002; 38:358.
41. Wildig J, Michon P, Siba P, Mellombo M., Ura A., Mueller I., Cos-sart Y. Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis. 2006; 194:146. DOI: 10.1086/505082.
42. Shimamura A., Guinan G. Acquired aplastic anemia. Nathan and Oski's Hematology of Infancy and Childhood, WB Saunders, Philadelphia 2003; 6: 256.
43. Rodis J.F., Quinn D.L., Gary G.W Jr., Anderson LJ., Rosengren S., Cartter M.L., Campbell W.A., Vintzileos A.M. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol. 1990; 163:1168.
44. Shipulin G.A., Belkovskaya M.E., Malmberg O.L., Shipulina O.Yu., Kurtser M.A., Lukash E.N., Gnetetskaya V.A., Piksasova O.V., Tarasоva Yu.A. Non-immune dropsy of the fetus: diagnosis and tactics. Akusherstvo i Ginekologiya=Obstetrics and Gynecology 2009; 2: 37—40. (In Russ.)
45. Enders M., Weidner A., Zoellner I., Searle K., Enders G. Fetal morbidity and mortality after acute human parvovirus B1 9 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn. 2004; 24:513.
46. Lassen J, Jensen AK, Bager P, et al. Pedersen CB, Panum I., Nar-gaard-Pedersen B., Aaby P., Wohlfahrt J., Melbye M. Parvovirus B19 infection in the first trimester of pregnancy and risk of fetal loss: a population-based case-control study. Am J Epidemiol. 2012; 176:803.
47. Ergaz Z., Ornoy A. Parvovirus B19 in pregnancy. Reprod Toxicol. 2006; 21:421.
48. deHaan T.R., Beersma M.., Oepkes D., de Jong E.P., Kroes A.C., Walther FJ. Parvovirus B1 9 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters. Prenat Diagn. 2007; 27:46.
49. Aguiar F.S., Lopes D.P., Bazin A.R. Human parvovirus B19 infection in HIV-positive patients. RevSoc Bras Med Trop. 2001; 34:239.
50. Heegaard E.D., Schmiegelow K. Serologic study on parvovirus b1 9 infection in childhood acute lymphoblastic leukemia during chemotherapy: clinical and hematologic implications. J Pediatr.Hema-tol.Oncol. 2002; 24:368.
51. Pakkyara A., Jha A., Al. Salmi I., W.A. Siddiqi, Al Rahbi N., A.P. Kurku-lasurya, J. Mohsin Persistent anemia in a kidney transplant recipient with parvovirus B19 infection. Saudi J Kidney Dis Transpl. 2017; 28:1447.
52. Eid AJ., Brown R.A., Patel R., Razonable R.R. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006; 43:40.
53. Zerbini M., Gallinella G., Cricca M., Bonvicini F, Musiani M. Diagnostic procedures in B19 infection. Pathol Biol (Paris). 2002; 50: 332—338.
54. Butchko A.R., Jordan J.A. Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J ClinMicrobiol. 2004; 42:3191.
55. Toppinen M, Norja P, Aaltonen LM, S.Wessberg, L. Hedman, M. Soderlund-Venermo, K. Hedman. A new quantitative PCR for human parvovirus B19 genotypes. J Virol Methods. 2015; 218:40. Doi: 10.1016/J.jviromet.2015.03.006.
56. Cassinotti P., Burtonboy G., Fopp M., Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997; 53:229.
57. Bonvicini F., Bua G., Manaresi E., Gallinella G. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells. Virus Res. 2016; 220:47.
58. Bonvicini F, Bua G., Conti I., Manaresi E., Gallinella G. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells. Biochem Pharmacol. 2017; 136: 32.
59. Crabol Y, Terrier B., Rozenberg F, Pestre V, Legendre C., Hermine O., Montagnier-Petrissans C., Guillevin L., Mouthon L. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis. 2013; 56:968.
60. Koduri P.R. Parvovirus B19-related anemia in HIV-infected patients. AIDS Patient Care STDS. 2000; 14(1):7.
61. Chen M.Y., Hung C.C., Fang C.T., Hsieh S.M. Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy. Clin Infec Dis. 2001; 32:1361.
62. Seng C., Watkins P., Morse D., Barrett S.P., Zambon M., Andrews N., Atkins M., Hall S., Lau Y.K., Cohen BJ. Parvovirus B19 outbreak on an adult ward. Epidemiol Infect. 1994; 11 3:345.
63. Garner J.S. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996; 17:53.
64. Chandramouli S., Medina-Selby A., Coit D., Schaefer M., Spencer T., Brito L.A., Zhang P., Otten G., Mandl C.W., Mason P.W., Dormitzer P.R., Settembre E.C. Generation of a parvovirus B19 vaccine candidate. Vaccine. 2013; 31:3872.
Review
For citations:
Anokhin V.A., Sabitova A.M., Aglyamova T.A., Minaeva E.Y., Marchenkova N.A., Knyazeva O.Y. Parvovirus infection in children. CHILDREN INFECTIONS. 2019;18(1):22-28. (In Russ.) https://doi.org/10.22627/2072-8107-2019-18-1-22-28
Views:
1941
Email this article 